BRIEF published on 11/20/2025 at 12:11, 11 months 18 days ago Zürcher Kantonalbank Discloses Position in Cicor Technologies Ltd. Takeover Code Financial Disclosure Shareholding Cicor Technologies Zürcher Kantonalbank
PRESS RELEASE published on 11/20/2025 at 12:06, 11 months 18 days ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zürcher Kantonalbank disclosed a 1.02% interest in Cicor Technologies Ltd. on 19th November 2025. Details on securities ownership and derivative transactions provided Securities Transactions Disclosure Zürcher Kantonalbank Cicor Technologies Ltd.
BRIEF published on 11/19/2025 at 13:05, 11 months 19 days ago Zürcher Kantonalbank's Disclosure on Cicor Technologies Ltd Takeover Code Securities Disclosure Shareholding Cicor Technologies Zürcher Kantonalbank
BRIEF published on 11/19/2025 at 13:05, 11 months 19 days ago Divulgation de la Banque Cantonale de Zurich concernant Cicor Technologies SA Actionnariat Code De Prise De Contrôle Cicor Technologies Banque Cantonale De Zurich Information Sur Les Valeurs Mobilières
PRESS RELEASE published on 11/19/2025 at 13:00, 11 months 19 days ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd. Zürcher Kantonalbank (0QPR) discloses a 1.01% interest in Cicor Technologies Ltd. through a Form 8.3 filing Form 8.3 Disclosure Zürcher Kantonalbank Cicor Technologies Ltd. 0QPR
BRIEF published on 11/18/2025 at 18:45, 11 months 20 days ago La Banque Cantonale de Zurich annonce sa position dans Cicor Technologies SA. Actionnariat Divulgation Cicor Technologies Formulaire 8.3 Banque Cantonale De Zurich
BRIEF published on 11/18/2025 at 18:45, 11 months 20 days ago Avis de correction concernant la divulgation de Cicor Technologies Ltd Cicor Technologies Formulaire 8.3 Opérations Sur Titres Banque Cantonale De Zurich Correction De La Divulgation
BRIEF published on 11/18/2025 at 18:45, 11 months 20 days ago Correction Notice on Cicor Technologies Ltd Disclosure Form 8.3 Securities Transactions Cicor Technologies Zürcher Kantonalbank Disclosure Correction
BRIEF published on 11/18/2025 at 18:45, 11 months 20 days ago Zürcher Kantonalbank Discloses Position in Cicor Technologies Ltd. Form 8.3 Disclosure Shareholding Cicor Technologies Zürcher Kantonalbank
BRIEF published on 11/18/2025 at 18:45, 11 months 20 days ago Correction to Zürcher Kantonalbank's Disclosure on Cicor Technologies Form 8.3 Securities Ownership Cicor Technologies Disclosure Correction Zurich Kantonalbank
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:15, 50 minutes ago EQS-Adhoc: Airbus SE: Airbus commences multi-year share buyback programme, with launch of the first tranche
Published on 11/09/2026 at 08:05, 1 hour ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 1 hour 5 minutes ago Aquis Stock Exchange: Transfer to Apex segment
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 2 hours 5 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
